Immediate Impact
59 standout
Citing Papers
Infectious Diseases Society of America 2024 Guidance on the Treatment of Antimicrobial-Resistant Gram-Negative Infections
2024 Standout
Fezolinetant for treatment of moderate-to-severe vasomotor symptoms associated with menopause (SKYLIGHT 1): a phase 3 randomised controlled study
2023 Standout
Works of W. D. Paar being referenced
Pharmacokinetics of piperacillin–tazobactam: intermittent dosing versus continuous infusion
2004
Sparteine oxidation polymorphism: phenotyping by measurement of sparteine and its dehydrometabolites in plasma
1989
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| W. D. Paar | 113 | 194 | 36 | 175 | 126 | 14 | 527 | |
| Rosario Calvo | 90 | 89 | 69 | 88 | 75 | 29 | 460 | |
| R. Hendriks | 50 | 65 | 98 | 82 | 147 | 14 | 573 | |
| K. K. Adjepon-Yamoah | 180 | 37 | 42 | 94 | 66 | 24 | 516 | |
| J. C. Levron | 98 | 38 | 60 | 60 | 158 | 35 | 614 | |
| R. G. Moore | 55 | 26 | 35 | 83 | 75 | 20 | 522 | |
| Arthur J. McBay | 45 | 41 | 47 | 167 | 49 | 38 | 608 | |
| E. F. S. Termond | 79 | 18 | 55 | 123 | 74 | 25 | 534 | |
| Ronald C. Backer | 40 | 36 | 87 | 60 | 69 | 32 | 475 | |
| T.B. Vree | 61 | 20 | 47 | 116 | 116 | 28 | 494 | |
| S. BOWER | 43 | 44 | 22 | 60 | 265 | 20 | 598 |
All Works
Loading papers...